新冠疫情时代下的印度结核病控制。
TB control in India in the COVID era.
机构信息
Dept. of Pulmonary Medicine, WHO Collaborating Centre for Research & Capacity Building in Chronic Respiratory Diseases, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India; National Task Force (NTEP/RNTCP).
出版信息
Indian J Tuberc. 2021 Jan;68(1):128-133. doi: 10.1016/j.ijtb.2020.08.019. Epub 2020 Aug 28.
Abstract
COVID-19 pandemic has disturbed the delivery of health care in almost all countries of the world. This has affected mostly the public health control programs. Because of lock downs, restrictions in movement, psychological fear of contacting the disease in health care facilities, diversion of health care workers for containment and management of COVID-19, utilization of diagnostic facilities like CBNAAT machines for COVID work, conversion of hospitals for care of these patients, financial diversion etc has created issues in the NTEP to focuss on TB control in India. Case notification and other areas of the program to achieve End TB by 2025 have suffered. Various ways of overcoming these difficulties have been discussed.
摘要
COVID-19 大流行几乎扰乱了世界上所有国家的医疗保健服务提供。这主要影响了公共卫生控制计划。由于封锁、行动限制、在医疗保健机构接触疾病的心理恐惧、医护人员转移以遏制和管理 COVID-19、用于 COVID 工作的 CBNAAT 等诊断设施的利用、医院转为这些患者的护理、资金转移等，印度国家结核病控制项目（NTEP）在专注于结核病控制方面遇到了问题。病例报告和该项目的其他领域，以实现到 2025 年终止结核病的目标，都受到了影响。已经讨论了克服这些困难的各种方法。
相似文献
1
TB control in India in the COVID era.
Indian J Tuberc. 2021 Jan;68(1):128-133. doi: 10.1016/j.ijtb.2020.08.019. Epub 2020 Aug 28.
2
Tuberculosis management in India during COVID-19 crisis.
J Public Health Policy. 2021 Mar;42(1):185-189. doi: 10.1057/s41271-020-00265-8. Epub 2020 Nov 24.
3
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.
BMC Health Serv Res. 2024 Aug 7;24(1):907. doi: 10.1186/s12913-024-11131-8.
4
Care of tuberculosis patients in the times of COVID-19.
Indian J Tuberc. 2021 Apr;68(2):285-286. doi: 10.1016/j.ijtb.2020.09.004. Epub 2020 Sep 5.
5
Impact of COVID-19 Pandemic on Tuberculosis Care and Treatment in Puducherry - A Mixed Method Study.
Indian J Public Health. 2023 Oct 1;67(4):626-631. doi: 10.4103/ijph.ijph_1406_22. Epub 2023 Dec 29.
6
TB care for women and Covid-A double health crisis in the offing?
Health Care Women Int. 2020 Nov-Dec;41(11-12):1226-1239. doi: 10.1080/07399332.2020.1837135.
7
The effect of the Covid-19 pandemic on Tuberculosis (TB) case notification in Ogun State, Nigeria.
Afr Health Sci. 2023 Sep;23(3):376-383. doi: 10.4314/ahs.v23i3.44.
8
Changing patterns of household transmission of tuberculosis in an eastern state of India: The impact of COVID19 pandemic.
Indian J Tuberc. 2022 Oct;69(4):682-689. doi: 10.1016/j.ijtb.2022.03.001. Epub 2022 Mar 11.
9
The untimely demise of the TB Free block model in the wake of coronavirus disease 2019 in India.
Trans R Soc Trop Med Hyg. 2020 Nov 6;114(11):789-791. doi: 10.1093/trstmh/traa067.
10
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21. doi: 10.1186/s12941-020-00363-1.
引用本文的文献
1
Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
PLOS Glob Public Health. 2025 Jan 7;5(1):e0003309. doi: 10.1371/journal.pgph.0003309. eCollection 2025.
2
Analyzing risk factors of tuberculosis using type-2 interval-valued trapezoidal fuzzy numbers with Einstein aggregation operators extended to MCDM.
Heliyon. 2024 Aug 12;10(16):e35997. doi: 10.1016/j.heliyon.2024.e35997. eCollection 2024 Aug 30.
3
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.
BMC Health Serv Res. 2024 Aug 7;24(1):907. doi: 10.1186/s12913-024-11131-8.
4
Impact of COVID-19 on child tuberculosis hospitalization.
Tunis Med. 2024 Jul 5;102(7):410-414. doi: 10.62438/tunismed.v102i7.4923.
5
Epidemiological and Time Series Analysis of Tuberculosis with Prediction during COVID-19 Pandemic using ARIMA Model: A Study from Churu District of Rajasthan.
Indian J Community Med. 2023 Nov-Dec;48(6):926-929. doi: 10.4103/ijcm.ijcm_681_22. Epub 2023 Dec 1.
6
Impact on Tuberculosis Notification During COVID-19 Pandemic in India: A Narrative Review.
Cureus. 2023 Aug 25;15(8):e44087. doi: 10.7759/cureus.44087. eCollection 2023 Aug.
7
Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria-A systematic review.
PLOS Glob Public Health. 2023 May 1;3(5):e0001018. doi: 10.1371/journal.pgph.0001018. eCollection 2023.
8
Tuberculosis and COVID-19: An epidemic submerged in the pandemic: A case series and review of current literature.
J Family Med Prim Care. 2022 Oct;11(10):6576-6580. doi: 10.4103/jfmpc.jfmpc_258_22. Epub 2022 Oct 31.
9
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts.
Trials. 2022 Aug 5;23(1):635. doi: 10.1186/s13063-022-06503-6.
10
COVID-19: a boon or a bane for the microbiologists.
Indian J Med Microbiol. 2022 Jan-Mar;40(1):7-11. doi: 10.1016/j.ijmmb.2021.12.020. Epub 2022 Jan 19.
本文引用的文献
1
Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020.
2
COVID-19: ensuring continuity of TB services in the private sector.
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):870-872. doi: 10.5588/ijtld.20.0400.
3
COVID-19 and tuberculosis-threats and opportunities.
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):757-760. doi: 10.5588/ijtld.20.0387.
4
COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity' or 'death'.
J Infect. 2020 Sep;81(3):e39-e40. doi: 10.1016/j.jinf.2020.06.062. Epub 2020 Jun 29.
5
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.
6
The (in)significance of TB and COVID-19 co-infection.
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.02105-2020. Print 2020 Aug.
7
Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.
Clin Infect Dis. 2021 Jan 23;72(1):79-81. doi: 10.1093/cid/ciaa747.
8
Tuberculosis in the time of COVID-19: quality of life and digital innovation.
Eur Respir J. 2020 Aug 6;56(2). doi: 10.1183/13993003.01998-2020. Print 2020 Aug.
9
Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01708-2020. Print 2020 Jul.
10
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
Eur Respir J. 2020 Jul 23;56(1). doi: 10.1183/13993003.01369-2020. Print 2020 Jul.
Zotero 插件